BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25073826)

  • 1. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].
    Burón A; Grau J; Andreu M; Augé JM; Guayta-Escolies R; Barau M; Macià F; Castells A;
    Med Clin (Barc); 2015 Aug; 145(4):141-6. PubMed ID: 25073826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of colorectal cancer screening using an immunological assay in a basic urban health area].
    García-Rodríguez MA; Cubillo-Durán E; Moreno-Camelo S; Mata-Román L; Muñoz-Moreno MF; Cáceres-Pereira A
    Semergen; 2013; 39(5):252-8. PubMed ID: 23834975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():64-70. PubMed ID: 26520198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colorectal cancer screening programme in Aragon (Spain): preliminary results].
    Solé Llop ME; Cano Del Pozo M; García Montero JI; Carrera-Lasfuentes P; Lanas Á
    Gac Sanit; 2018; 32(6):559-562. PubMed ID: 28784304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
    Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
    Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluating colorectal cancer screening strategies (immunological test vs biochemical test) in Catalonia, Spain 2008-2010].
    García Martínez M; Binefa Rodríguez G; Milà Díaz N; Rodríguez Moranta F; Gonzalo Diego N; Muñoz Sánchez C; Espinàs Piñol JA; Borràs Andrés JM; Moreno Aguado V
    Rev Esp Salud Publica; 2011 Dec; 85(6):593-602. PubMed ID: 22249590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
    McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
    Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organized colorectal cancer screening in Serbia - the first round within 2013-2014.
    Banković Lazarević D; Krivokapić Z; Barišić G; Jovanović V; Ilić D; Veljković M
    Vojnosanit Pregl; 2016 Apr; 73(4):360-7. PubMed ID: 29309104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colorectal cancer screening: where are we and where are we going?].
    Fantin A; Chiarioni G
    Recenti Prog Med; 2013 Feb; 104(2):45-8. PubMed ID: 23535955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a nationwide screening colonoscopy program for colorectal cancer.
    Pox CP; Altenhofen L; Brenner H; Theilmeier A; Von Stillfried D; Schmiegel W
    Gastroenterology; 2012 Jun; 142(7):1460-7.e2. PubMed ID: 22446606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; de Pretis G; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex DK; Zappa M; Hassan C;
    Gut; 2017 Jul; 66(7):1233-1240. PubMed ID: 26896459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching.
    Leuraud K; Jezewski-Serra D; Viguier J; Salines E
    Cancer Epidemiol; 2013 Dec; 37(6):959-67. PubMed ID: 24035240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of indicators to evaluate colorectal cancer prevention programs in the high-risk population: the experience of a high-risk colorectal cancer clinic].
    Serra Sutton V; Espallargues M; Balaguer F; Castells A
    Gastroenterol Hepatol; 2012 Nov; 35(9):613-24. PubMed ID: 22749512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.